Law ❯ Litigation ❯ Securities Litigation ❯ Corporate Law

Investor Advocacy

Corcept Investors Face April 21 Deadline to Seek Lead Role in Securities Case Over Relacorilant

Plaintiffs say Corcept misled the market about FDA concerns with relacorilant's evidence.

Law Firms Set April 7 Deadline for Investors to Lead Inovio Securities Class Action

Law Firms Urge Corcept Investors To Seek Lead Role In Securities Case Before April 21

Lead Plaintiff Deadline Set in James Hardie Inventory-Fraud Class Action